Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human bone marrow-derived mesenchymal stem cells (Human BM-MSCs): Control (recombinant human LIGHT, rhLIGHT 0 ng/ml) vs rhLIGHT 200 ng/ml

ABSTRACT: Transcriptional profiling of Human BM-MSCs comparing between control (BSA-treated) and rhLIGHT treated human BM-MSCs at 72hr

ORGANISM(S): Homo sapiens

PROVIDER: GSE85895 | GEO | 2016/08/23

SECONDARY ACCESSION(S): PRJNA339699

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Human bone marrow-derived mesenchymal stem cells (Human BM-MSCs): Control (recombinant human LIGHT, rhLIGHT 0 ng/ml) vs rhLIGHT 200 ng/ml

Project description:Transcriptional profiling of Human BM-MSCs comparing between control (BSA-treated) and rhLIGHT treated human BM-MSCs at 72hr one-condition experiment, Control (rhLIGHT 0 ng/ml) vs rhLIGHT 200 ng/ml. Biological replicates: 1.

2016-08-23 | E-GEOD-85895 | biostudies-arrayexpress

Gene expression profiling of low-dose irradiated human BM-MSCs

Project description:In bone marrow (BM), there are two different types of stem/progenitor cells. With respect to hematopoiesis, hematopoietic stem/progenitor cells (HPCs) produce mature blood cells and mesenchymal stromal/stem cells (MSCs) support this. The influence of exposure to low-dose radiation on human HPCs has been investigated, and generation of both immature and mature hematopoietic cells from human HPCs is compromised. On the other hand, the influence of exposure to low-dose radiation on MSCs is not known. This gene expression profiling was created for investigation how low-dose irradiation affects BM-MSCs genomically.

2017-09-01 | GSE97368 | GEO

RNA-seq of human BM-derived mesenchymal stromal cells (MSCs) cocultured with mouse BM cells upon GM-CSF stimulation against MSCs without BM cell coculture

Project description:RNA-seq of human BM-derived mesenchymal stromal cells (MSCs) cocultured with mouse BM cells upon GM-CSF stimulation against MSCs without BM cell coculture

| PRJEB37926 | ENA

RNA-seq of human BM-derived mesenchymal stromal cells (MSCs) cocultured with mouse BM cells upon GM-CSF stimulation against MSCs without BM cell coculture

Project description:The paracrine factors are to be identified from MSCs that induce BM cell differentiation during inflammation.

2020-05-01 | E-MTAB-8976 | biostudies-arrayexpress

ChIP-on-chip from multiple donors of BM-MSCs with H3K4me3 and H3K27me3

Project description:Bone marrow-derived multipotent stromal cells (BM-MSCs) exhibit therapuetically valuable properties, including the capacity to differentiate into skeletal tissues and modulate immune system activity. These properties depend on proper regulation of dynamic gene expression in response to environmental and developmental stimuli. This study used chromatin immunoprecipitation (ChIP) coupled with human promoter tiling microarray analysis (ChIP-on-chip) to profile histones H3K4me3 and H3K27me3 at promoters genome-wide. The goal of the study was to identify gene promoters marked by H3K27me3 and H3K4me3 in BM-MSCs.

2015-02-09 | GSE64172 | GEO

Effect of PROTAC-mediated BRD4 degradation on bone marrow-derived mesenchymal stromal cells [BM-MSCs]

Project description:BRD4, a member of the BET family of histone readers, binds to acetylated lysine of histone H3 and promotes assembly of super-enhancer complexes that drive expression of key oncogenes in acute myeloid leukemia (AML) and other cancers. ARV-825 is a proteolysis-targeting chimera (PROTAC) that targets BRD4 for CRBN-mediated ubiquitination and degradation. BM-MSCs are an important element of the bone marrow microenvironment of AML. To understand how targeting BRD4 in BM-MSCs may contribute to the overall effect on AML of targeting BRD4, we treated BM-MSCs from two normal donors with ARV-825 in vitro. Treatment of BM-MSC monocultures with ARV-825 for 24 hr caused extensive changes in gene expression, highly uniform between triplicates. Although the cultures from the two normal donors showed different profiles, their changes with ARV-825 were highly similar. These changes implicated effects on oxidative stress, osteogenic differentiation, retinoid metabolism, F-actin polymerization, CXCL12, and proliferation.

2019-10-01 | GSE101449 | GEO

PDGFB-expressing MSCs improve human hematopoietic stem cell engraftment in immunodeficient mice

Project description:The bone marrow (BM) niche regulates multiple HSC processes. Clinical treatment for hematological malignancies, by HSC transplantation often requires preconditioning total body irradiation, which severely and irreversibly impairs the BM niche and HSC regeneration. Novel strategies to enhance HSC regeneration in irradiated BM are needed. We compared the effects of niche factors EGF, FGF2 and PDGFB on HSC hematopoietic regeneration using human MSCs that were transduced with these factors via lentiviral vectors. Among above niche factors tested, PDGFB-MSCs most significantly improved human hematopoietic cell engraftment in immunodeficient mice. PDGFB-MSC-treated BM more efficiently enhanced transplanted human HSC self-renewal in secondary transplantations from primary recipients. Although PDGFB-MSCs did not directly increase HSC expansion in vitro, GSEA revealed anti-apoptotic signaling being increased in PDGFB-MSCs versus GFP-MSCs. PDGFB-MSCs had enhanced survival and expansion after transplantation, leading to an enlarged humanized niche cell pool. Our study demonstrates the efficacy of MSC-mediated niche factors in clinical HSC transplantation for patients.

2020-06-22 | GSE113857 | GEO

ChIP-on-chip from multiple donors of BM-MSCs with H3K4me3 and H3K27me3

2015-02-09 | E-GEOD-64172 | biostudies-arrayexpress

Microarray data from BM-MSCs exposed to DMSO, LG268, Rosi, TPhP, TBT, and MEHP

Project description:Primary mouse bone marrow mesenchymal stromal cells (BM-MSCs) cultured for bone differentiation were exposed to vehicle (DMSO), synthetic RXR ligand (LG100268), type 2 diabetes therapeutic and PPARγ ligand (Rosiglitazone), and environmental PPARγ ligands (Tributyltin, Triphenyl Phosphate, and MEHP) to evaluate differential gene expression as well as nuclear receptor expression and downstream PPARG target gene expression between all chemical exposures

2018-09-06 | GSE119541 | GEO

Microarray data from BM-MSCs exposed to DMSO, LG268, Rosi, TPhP, TBT, and MEHP

Project description:Microarray data from BM-MSCs exposed to DMSO, LG268, Rosi, TPhP, TBT, and MEHP

| PRJNA489487 | ENA